Marcella M. Johnson

7.6k citations

74 papers · 5.4k indexed · h-index 41

Impact in

Oncology top 0.5%
- Cutaneous Melanoma Detection and Management
- Bone health and treatments
- Cancer Diagnosis and Treatment
Gastroenterology top 2%
- Gastrointestinal Tumor Research and Treatment

Papers in

Oncology 39
- Cutaneous Melanoma Detection and Management 19
- Bone health and treatments 6
Immunology and Allergy 7
- Cell Adhesion Molecules Research 7

Co-authors: Víctor G. Prieto Jeffrey E. Gershenwald Merrick I. Ross Carla L. Warneke Jeffrey E. Lee Donald A. Podoloff Julie A. Ellerhorst Elizabeth A. Grimm
Journals: Journal of Clinical Oncology (13 papers)Cancer (9 papers)Clinical Cancer Research (7 papers)Blood (4 papers)Cancer Research (3 papers)
Partner nations: United States Australia United Kingdom

In The Last Decade

Marcella M. Johnson

74 papers receiving 5.3k citations

Peers

Countries citing papers authored by Marcella M. Johnson

Since Specialization

Citations

This map shows the geographic impact of Marcella M. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcella M. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcella M. Johnson more than expected).

Fields of papers citing papers by Marcella M. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcella M. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcella M. Johnson. The network helps show where Marcella M. Johnson may publish in the future.

Co-authors

The 25 scholars most cited alongside Marcella M. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marcella M. Johnson Line = papers co-authored together Marcella M. Johnson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Elevated Serum Leptin Levels are Associated With an Increased Risk of Sentinel Lymph Node Metastasis in Cutaneous Melanoma Medicine ·Junna Oba, Wei Wei, Jeffrey E. Gershenwald, Marcella M. Johnson, Tiina Alalääkkölä, Julie A. Ellerhorst, Elizabeth A. Grimm	2016	33
2	A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma Melanoma Research ·Kevin B. Kim, Víctor G. Prieto, Richard W. Joseph, A. Hafeez Diwan, Gary E. Gallick, Nicholas E. Papadopoulos, Agop Y. Bedikian, Luis H. Camacho, Patrick Hwu, Chaan S. Ng, Wei Wei, Marcella M. Johnson, Qing-yu Zhang, Narayan Chandra Bhowmik, Felipe Antonio Donoso Aguirre, A. Dimitrios Colevas	2012	58
3	Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database Journal of Clinical Oncology ·John F. Thompson, Seng-Jaw Soong, Charles M. Balch, Jeffrey E. Gershenwald, Shouluan Ding, Daniel G. Coit, Keith T. Flaherty, Phyllis A. Gimotty, T. M. Johnson, Marcella M. Johnson, Stanley P. L. Leong, Merrick I. Ross, David R. Byrd, Natale Cascinelli, Alistair J. Cochran, Alexander M.M. Eggermont, Kelly M. McMasters, Martín C. Mihm, Donald L. Morton, Vernon K. Sondak	2011	250
4	Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma Clinical Cancer Research ·Julie A. Ellerhorst, Victoria R. Greene, Sühendan Ekmekçioglu, Carla L. Warneke, Marcella M. Johnson, 龍之介北原, Li‐E Wang, Víctor G. Prieto, Jeffrey E. Gershenwald, Qingyi Wei, Elizabeth A. Grimm	2010	187
5	Does complete response to systemic therapy in patients with stage IV melanoma translate into long-term survival? Melanoma Research ·Agop Y. Bedikian, Marcella M. Johnson, Carla L. Warneke, Nicholas E. Papadopoulos, Kevin B. Kim, Wen-Jen Hwu, Susan McIntyre, Michelle Rohlfs, Jade Homsi, Patrick Hwu	2010	7
6	Immunohistochemical detection of lymphovascular invasion with D2‐40 in melanoma correlates with sentinel lymph node status, metastasis and survival Journal of Cutaneous Pathology ·Fredrik Petersson, A. Hafeez Diwan, Doina Ivan, Jeffrey E. Gershenwald, Marcella M. Johnson, Robyn K. Harrell, Víctor G. Prieto	2009	62
7	Upfront, randomized, phase 2 trial of sorafenib versus sorafenib and low‐dose interferon alfa in patients with advanced renal cell carcinoma Cancer ·Eric Jonasch, Paul G. Corn, Lance C. Pagliaro, Carla L. Warneke, Marcella M. Johnson, Pheroze Tamboli, Chaan S. Ng, Ana M. Aparicio, Robynne Ashe, James R. Wright, Nizar M. Tannir	2009	95
8	TIMP-2 mediates the anti-invasive effects of the nitric oxide-releasing prodrug JS-K in breast cancer cells Breast Cancer Research ·Ann‐Marie Simeone, Derek A. Coss, René Nieves-Alicea, Joseph E. Saavedra, Larry K. Keefer, Marcella M. Johnson, Ana M. Tari	2008	48
9	Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic Melanoma Cancer Investigation ·Agop Y. Bedikian, Marcella M. Johnson, Carla L. Warneke, Nicholas E. Papadopoulos, Kevin Kim, Wen-Jen Hwu, Susan McIntyre, Patrick Hwu	2008	57
10	Frequencies of NRAS and BRAF Mutations Increase from the Radial to the Vertical Growth Phase in Cutaneous Melanoma Journal of Investigative Dermatology ·Victoria R. Greene, Marcella M. Johnson, Elizabeth A. Grimm, Julie A. Ellerhorst	2008	44
11	Cancer Patients With Markedly Elevated B-Type Natriuretic Peptide May Not Have Volume Overload American Journal of Clinical Oncology ·Pletnikova Tatiana Anatolevna, Maria Selviana Mia Pera, L. Xiao, Marcella M. Johnson, Salim Yusuf, Daniel J. Lenihan	2007	52
12	Quantitative Analysis of Melanocytic Tissue Array Reveals Inverse Correlation between Activator Protein-2α and Protease-Activated Receptor-1 Expression during Melanoma Progression Journal of Investigative Dermatology ·Carmen S. Tellez, Darren W. Davis, Víctor G. Prieto, Jeffrey E. Gershenwald, Marcella M. Johnson, Marya F. McCarty, Menashe Bar‐Eli	2006	36
13	Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma Cancer ·Timothy M. Pawlik, Merrick I. Ross, Víctor G. Prieto, Matthew T. Ballo, Marcella M. Johnson, Paul F. Mansfield, Jeffrey E. Lee, Janice N. Cormier, Jeffrey E. Gershenwald	2006	86
14	Tumor iNOS predicts poor survival for stage III melanoma patients International Journal of Cancer ·Sühendan Ekmekçioglu, Julie A. Ellerhorst, Víctor G. Prieto, Marcella M. Johnson, Lyle D. Broemeling, Elizabeth A. Grimm	2006	113
15	Clinical relevance of soluble HLA-I and β2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease Leukemia Research ·Maher Albitar, Julie M. Vose, Marcella M. Johnson, E. Trojanska, Amanda Day, Iman Jilani, Hagop M. Kantarjian, Michael J. Keating, Susan O’Brien, Srđan Verstovšek, Jamés O. Armitage, Francis J. Giles	2006	26
16	Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma Cancer ·Christopher J. Gannon, Dennis L. Rousseau, Merrick I. Ross, Marcella M. Johnson, Jeffrey E. Lee, Paul F. Mansfield, Janice N. Cormier, Víctor G. Prieto, Jeffrey E. Gershenwald	2006	74
17	Cyclooxygenase-2 Is Essential for HER2/ *neu* to Suppress N - (4-Hydroxyphenyl)retinamide Apoptotic Effects in Breast Cancer Cells Cancer Research ·Ann‐Marie Simeone, Yujiang Li, Lyle D. Broemeling, Marcella M. Johnson, Musaffe Tuna, Ana M. Tari	2004	39
18	Needle Localization for Excisional Biopsy of Breast Lesions: Comparison of Effect of Use of Full-Field Digital versus Screen-Film Mammographic Guidance on Procedure Time Radiology ·Wei Yang, Gary J. Whitman, Marcella M. Johnson, Luquan Ren, Anne C. Kushwaha, Kelly K. Hunt, Peter J. Dempsey	2004	2
19	Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti‐CD52 antibodies Cancer ·Maher Albitar, Kim‐Anh Do, Marcella M. Johnson, Francis J. Giles, Iman Jilani, Susan O’Brien, Jörge E. Cortes, Deborah A. Thomas, Laura Z. Rassenti, Thomas J. Kipps, Hagop M. Kantarjian, Michael J. Keating	2004	59
20	Biochemotherapy in patients with metastatic anorectal mucosal melanoma Cancer ·Kevin B. Kim, Ángela Sanguino, J.M. Bosselaar, Nicholas E. Papadopoulos, Omar Eton, Luis H. Camacho, Lyle D. Broemeling, Marcella M. Johnson, Matthew T. Ballo, Merrick I. Ross, Jeffrey E. Gershenwald, Jeffrey E. Lee, Paul F. Mansfield, Víctor G. Prieto, Agop Y. Bedikian	2004	62

About Marcella M. Johnson

Marcella M. Johnson is a scholar working on Oncology, Immunology and Allergy, Cancer Research, Genetics and Immunology, having authored 74 papers that have together received 5.4k indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (19 papers), Melanoma and MAPK Pathways (8 papers), Cell Adhesion Molecules Research (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Immunotherapy and Immune Responses (6 papers), Bone health and treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Oncology (2.9k citations), Gastroenterology (288 citations), Orthopedics and Sports Medicine (433 citations), Cancer Research (632 citations) and Immunology and Allergy (189 citations). Marcella M. Johnson has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Víctor G. Prieto, Jeffrey E. Gershenwald, Merrick I. Ross, Carla L. Warneke, Jeffrey E. Lee, Donald A. Podoloff, Julie A. Ellerhorst, Elizabeth A. Grimm, Paul F. Mansfield and Janice N. Cormier. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Clinical Cancer Research, Blood and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact